Abe K, Demizu A, Kamada K, Shimada Y, Sakaki T, Yoshiya I
Department of Anaesthesiology, Osaka Police Hospital, Japan.
Can J Anaesth. 1992 Mar;39(3):247-52. doi: 10.1007/BF03008785.
The purpose of this study was to evaluate the effect of prostaglandin E1 (PGE1) on CO2 reactivity during cerebral aneurysm surgery in 37 patients under neuroleptoanaesthesia (NLA). The patients were divided into two groups based on the timing of surgery (A: late surgery B: early surgery). In the early surgery group, aneurysm surgery was performed within three days of subarachnoid haemorrhage (SAH) and in the late surgery group surgery was performed more than four days after SAH. Presurgical neurological status was worse in the early surgery group than in the late surgery group (P less than 0.01). Local cerebral blood flow (LCBF) measurements were made using a thermal gradient blood flow meter. Hypotension was induced by PGE1 administration at an initial dose of 0.1 micrograms.kg-1.min-1 and adjusted to maintain the mean arterial pressure (MAP) at about 70 mmHg. The CO2 reactivity was calculated by the % change in LCBF divided by the change in PaCO2 (% delta LCBF/delta PaCO2 (%.mmHg-1)). LCBF, heart rate and mean arterial blood pressure were measured during and after PGE1 infusion. Carbon dioxide reactivity was measured before, during and after PGE1 administration. The LCBF did not change throughout the study but CO2 reactivity was greater in Group A (before hypotension: 2.74 +/- 0.85 %.mmHg-1, during hypotension: 2.54 +/- 0.73 % .mmHg-1, after hypotension: 2.59 +/- 1.17 %.mmHg-1) than in group B (before hypotension: 1.54 +/- 0.57%.mmHg-1, during hypotension: 1.56 +/- 0.59 %.mmHg-1, after hypotension: 1.49 +/- 0.42%.mmHg-1) (P less than 0.01). Outcome which was graded by Glasgow Outcome Scale at discharge, was better in Group A (P less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
本研究旨在评估前列腺素E1(PGE1)对37例接受神经安定麻醉(NLA)的脑动脉瘤手术患者术中二氧化碳反应性的影响。根据手术时间将患者分为两组(A组:晚期手术;B组:早期手术)。早期手术组在蛛网膜下腔出血(SAH)后三天内进行动脉瘤手术,晚期手术组在SAH后四天以上进行手术。早期手术组术前神经状态比晚期手术组差(P<0.01)。使用热梯度血流仪测量局部脑血流量(LCBF)。通过静脉输注PGE1诱导低血压,初始剂量为0.1微克·千克-1·分钟-1,并进行调整以维持平均动脉压(MAP)在约70mmHg。通过LCBF的变化百分比除以动脉血二氧化碳分压(PaCO2)的变化来计算二氧化碳反应性(%ΔLCBF/ΔPaCO2(%·mmHg-1))。在PGE1输注期间及之后测量LCBF、心率和平均动脉血压。在PGE1给药前、给药期间和给药后测量二氧化碳反应性。整个研究过程中LCBF未发生变化,但A组的二氧化碳反应性高于B组(低血压前:2.74±0.85%·mmHg-1,低血压期间:2.54±0.73%·mmHg-1,低血压后:2.59±1.17%·mmHg-1)(B组:低血压前:1.54±0.57%·mmHg-1,低血压期间:1.56±0.59%·mmHg-1,低血压后:1.49±0.42%·mmHg-1)(P<0.01)。出院时根据格拉斯哥预后评分分级的结果,A组更好(P<0.05)。(摘要截断于250字)